Baxter Divests Serum Business In Turkey Business Rejig
Executive Summary
In alignment with the global separation of its Baxalta biopharmaceutical business, Baxter will complete a major reorganization in Turkey by the end of the year that includes the sale of its local serum products portfolio and production equipment to a fast-growing local firm.